Human	O
papillomavirus	O
oncoprotein	O
E6	O
inactivates	O
the	O
transcriptional	O
coactivator	O
human	O
ADA3	O
.	O

High	O
-	O
risk	O
human	O
papillomaviruses	O
(	O
HPVs	O
)	O
are	O
associated	O
with	O
carcinomas	B-Cancer
of	O
the	O
cervix	B-Multi-tissue_structure
and	O
other	O
genital	B-Cancer
tumors	I-Cancer
.	O

The	O
HPV	O
oncoprotein	O
E6	O
is	O
essential	O
for	O
oncogenic	O
transformation	O
.	O

We	O
identify	O
here	O
hADA3	O
,	O
human	O
homologue	O
of	O
the	O
yeast	O
transcriptional	O
coactivator	O
yADA3	O
,	O
as	O
a	O
novel	O
E6	O
-	O
interacting	O
protein	O
and	O
a	O
target	O
of	O
E6	O
-	O
induced	O
degradation	O
.	O

hADA3	O
binds	O
selectively	O
to	O
the	O
high	O
-	O
risk	O
HPV	O
E6	O
proteins	O
and	O
only	O
to	O
immortalization	O
-	O
competent	O
E6	O
mutants	O
.	O

hADA3	O
functions	O
as	O
a	O
coactivator	O
for	O
p53	O
-	O
mediated	O
transactivation	O
by	O
stabilizing	O
p53	O
protein	O
.	O

Notably	O
,	O
three	O
immortalizing	O
E6	O
mutants	O
that	O
do	O
not	O
induce	O
direct	O
p53	O
degradation	O
but	O
do	O
interact	O
with	O
hADA3	O
induced	O
the	O
abrogation	O
of	O
p53	O
-	O
mediated	O
transactivation	O
and	O
G	O
(	O
1	O
)	O
cell	B-Cell
cycle	O
arrest	O
after	O
DNA	O
damage	O
,	O
comparable	O
to	O
wild	O
-	O
type	O
E6	O
.	O

These	O
findings	O
reveal	O
a	O
novel	O
strategy	O
of	O
HPV	O
E6	O
-	O
induced	O
loss	O
of	O
p53	O
function	O
that	O
is	O
independent	O
of	O
direct	O
p53	O
degradation	O
.	O

Given	O
the	O
likely	O
role	O
of	O
the	O
evolutionarily	O
conserved	O
hADA3	O
in	O
multiple	O
coactivator	O
complexes	O
,	O
inactivation	O
of	O
its	O
function	O
may	O
allow	O
E6	O
to	O
perturb	O
numerous	O
cellular	B-Cell
pathways	O
during	O
HPV	O
oncogenesis	O
.	O

